Home Cart Sign in  
Chemical Structure| 28822-58-4 Chemical Structure| 28822-58-4

Structure of IBMX
CAS No.: 28822-58-4

Chemical Structure| 28822-58-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

IBMX is a competitive nonselective PDEs inhibitor and a nonselective adenosine receptor antagonist, with IC50 of 2-50 μM but does not inhibit PDE8 or PDE9.

Synonyms: 3-Isobutyl-1-methylxanthine; Isobutylmethylxanthine; SC-2964

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of IBMX

CAS No. :28822-58-4
Formula : C10H14N4O2
M.W : 222.24
SMILES Code : O=C(N1C)N(CC(C)C)C2=C(NC=N2)C1=O
Synonyms :
3-Isobutyl-1-methylxanthine; Isobutylmethylxanthine; SC-2964
InChI Key :APIXJSLKIYYUKG-UHFFFAOYSA-N
Pubchem ID :3758

Safety of IBMX

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
3T3-L1 pre-adipocytes 500 μM 2 days Induction of pre-adipocyte differentiation into adipocytes PMC3449261
Rat ventricular myocardium 30 µM 15 minutes To study the effects of IBMX on the positive inotropic response to glucagon in rat ventricular myocardium. Results showed that IBMX enhanced the inotropic effect of glucagon and altered its EC50 value. PMC10230788
Nonfailing and failing human myocardial tissue 30 µM 15 minutes To investigate the positive inotropic effects of IBMX on nonfailing and failing human myocardial tissues. Results showed that IBMX induced a marked inotropic response in atrial tissues from nonfailing hearts but no response in failing hearts. Ventricular tissues showed stronger responses in nonfailing hearts. PMC10230788
Mouse embryonic fibroblasts (MEFs) 500 μM 2 days Induction of pre-adipocyte differentiation into adipocytes PMC3449261
Aged mouse right atrial tissue 100 µM 20 minutes IBMXmax increased cAMP levels in both adult and aged atrial tissue by the same degree. PMC9886694
Adult mouse right atrial tissue 5 µM 20 minutes IBMX50 increased cAMP levels in both adult and aged atria, but to a greater magnitude in the former. PMC9886694
Hepatocytes 0.5 mM 20 minutes To investigate the effect of IBMX on mitochondrial respiratory chain complex I and CPS-I activity. Results showed that IBMX inhibited mitochondrial respiratory chain complex I and CPS-I activity. PMC2397462
Porcine oocytes 1.0 mM 24 hours Inhibition of GVBD and increase in MIR21 abundance PMC7212575
Mouse pancreatic acini 0.03-1.0 mM 30 min IBMX potentiated amylase release stimulated by CCK, carbamylcholine, and the ionophore A23187 by mimicking the action of cyclic AMP. PMC1199349
B16/F10 melanoma cells 100 mM 48 hours To evaluate the melanogenic effect induced by IBMX, results showed IBMX treatment significantly increased melanin content PMC7146600
Mesenchymal stem cells (MSCs) 100 μM 5 days Induced neural-like differentiation of MSCs, including expression of neural markers and increased sensitivity to neurotransmitters PMC6393535
Mouse PCLS 1 mM 50 minutes Used as a positive control for maximal relaxation, compared with amitriptyline PMC10617234
Rat PCLS 1 mM 50 minutes Used as a positive control for maximal relaxation, compared with amitriptyline PMC10617234
Colon fragments 100 µM 60 minutes IBMX stimulation resulted in a 100% increase in GLP-1 release PMC7782689
Antral fragments 100 µM 60 minutes IBMX stimulation resulted in an 80% increase in GLP-1 release PMC7782689
Fundus fragments 100 µM 60 minutes IBMX stimulation resulted in a 70% increase in GLP-1 release PMC7782689
Gallbladder smooth muscle cells 100 μM To investigate the effect of IBMX on cAMP levels in gallbladder smooth muscle cells and its role in gallbladder relaxation. Results showed that IBMX increased cAMP levels by inhibiting phosphodiesterase, leading to gallbladder smooth muscle relaxation. PMC1575959
Rat gastric mucosa parietal cells 1 μM-100 μM IBMX caused concentration-dependent increases in acid output, unaffected by ranitidine, indicating direct action on parietal cells without histamine release. PMC1915956
Mouse oviduct smooth muscle cells 10 μM IBMX mimicked the effects of caffeine, causing membrane hyperpolarization and inhibition of slow wave activity, which were reversed by the KATP channel antagonist glibenclamide. PMC3111677
Fischer rat thyroid (FRT) epithelial cells 100 µM Activation of CFTR channel by increasing intracellular cAMP levels, used to study CFTR function PMC11764695
Human nasal epithelial cells (HNEC) 100 µM Activation of CFTR channel by increasing intracellular cAMP levels, used to study CFTR function PMC11764695

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Sprague-Dawley rats Liver perfusion system Perfusion 0.5 mM 45 minutes To investigate the effect of IBMX on hepatic urea synthesis. Results showed that IBMX inhibited urea synthesis, and AGM reversed this inhibition. PMC2397462
Guinea-pigs Gallbladder muscle strips Organ bath 100 μM Single administration To study the relaxing effect of IBMX on gallbladder muscle strips. Results showed that IBMX caused gallbladder smooth muscle relaxation by increasing cAMP levels, with a relaxation amplitude of 6.4±1.1 mN. PMC1575959
Rat Rat right atria In vitro administration 30 µM Single dose, 15 minutes To investigate the effects of IBMX on the spontaneous beating rate of rat right atria. Results showed that IBMX increased the atrial rate but did not alter the chronotropic effect of glucagon. PMC10230788

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.50mL

0.90mL

0.45mL

22.50mL

4.50mL

2.25mL

45.00mL

9.00mL

4.50mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories